Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia.

<h4>Background</h4>In patients with acute myeloid leukemia (AML), the presence or absence of recurrent cytogenetic aberrations is used to identify the appropriate therapy. However, the current classification system does not fully reflect the molecular heterogeneity of the disease, and treatment stra... View More